Correction to: Genistein downregulates onco-miR-1260b and upregulates sFRP1 and Smad4 via demethylation and histone modification in prostate cancer cells (British Journal of Cancer, (2014), 110, 6, (1645-1654), 10.1038/bjc.2014.48);Genistein downregulates onco-miR-1260b and upregulates sFRP1 and Smad4 via demethylation and histone modification in prostate cancer cells

British Journal of Cancer

Volumn 110, Issue 6, 2014, Pages 1645-1654

  Hirata, H ^a   Hinoda, Y ^b   Shahryari, V ^a   Deng, G ^a   Tanaka, Y ^a   Tabatabai, Z L ^c   Dahiya, R ^a  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b YAMAGUCHI UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

apoptosis; genistein; miR 1260b; PC; sFRP1; Smad4

Indexed keywords

GENISTEIN; MICRORNA; MICRORNA 1260B; SECRETED FRIZZLED RELATED PROTEIN 1; SMAD4 PROTEIN; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; ARTICLE; CANCER CELL; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CELL VIABILITY; CELL VIABILITY ASSAY; CLINICAL ARTICLE; CONTROLLED STUDY; DEMETHYLATION; DNA METHYLATION; DNA SEQUENCE; HISTONE MODIFICATION; HUMAN; HUMAN CELL; LUCIFERASE ASSAY; MALE; PRIORITY JOURNAL; PROMOTER REGION; PROSTATE CANCER; PROSTATE EPITHELIUM; PROSTATE HYPERTROPHY; PROTEIN EXPRESSION;

ANTICARCINOGENIC AGENTS; ATAXIA TELANGIECTASIA MUTATED PROTEINS; DNA METHYLATION; DOWN-REGULATION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENISTEIN; HISTONES; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; MALE; MICRORNAS; PROSTATIC NEOPLASMS; SMAD4 PROTEIN; TISSUE ARRAY ANALYSIS; UP-REGULATION;

EID: 84896495101     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/s41416-018-0146-2     Document Type: Erratum

References (46)

1. Ahmad A, Biersack B, Li Y, Bao B, Kong D, Ali S, Banerjee S, Sarkar FH (2013) Perspectives on the role of isoflavones in prostate cancer. AAPS J 15: 991-1000.
2. Chan JM, Holick CN, Leitzmann MF, Rimm EB, Willett WC, Stampfer MJ, Giovannucci EL (2006) Diet after diagnosis and the risk of prostate cancer progression, recurrence, and death (United States). Cancer Causes Control 17: 199-208.
3. Chiyomaru T, Yamamura S, Fukuhara S, Hidaka H, Majid S, Saini S, Arora S, Deng G, Shahryari V, Chang I, Tanaka Y, Tabatabai ZL, Enokida H, Seki N, Nakagawa M, Dahiya R (2013) Genistein up-regulates tumor suppressor microRNA-574-3p in prostate cancer. PLoS One 8: e58929.
4. Cimino S, Sortino G, Favilla V, Castelli T, Madonia M, Sansalone S, Russo GI, Morgia G (2012) Polyphenols: key issues involved in chemoprevention of prostate cancer. Oxid Med Cell Longev 2012: 632959.
5. Clément G, Braunschweig R, Pasquier N, Bosman FT, Benhattar J (2006) Alterations of the Wnt signaling pathway during the neoplastic progression of Barrett's esophagus. Oncogene 25: 3084-3092.
6. Ding Z, Wu CJ, Chu GC, Xiao Y, Ho D, Zhang J, Perry SR, Labrot ES, Wu X, Lis R, Hoshida Y, Hiller D, Hu B, Jiang S, Zheng H, Stegh AH, Scott KL, Signoretti S, Bardeesy N, Wang YA, Hill DE, Golub TR, Stampfer MJ, Wong WH, Loda M, Mucci L, Chin L, DePinho RA (2011) SMAD4-dependent barrier constrains prostate cancer growth and metastatic progression. Nature 470: 269-273.
7. Fritz WA, Eltoum IE, Cotroneo MS, Lamartiniere CA (2002) Genistein alters growth but is not toxic to the rat prostate. J Nutr 132: 3007-3011.
8. Giehl K, Imamichi Y, Menke A (2007) Smad4-independent TGF-beta signaling in tumor cell migration. Cells Tissues Organs 185: 123-130.
9. Gomez SL, Noone AM, Lichtensztajn DY, Scoppa S, Gibson JT, Liu L, Morris C, Kwong S, Fish K, Wilkens LR, Goodman MT, Deapen D, Miller BA (2013) Cancer incidence trends among asian american populations in the United States, 1990-2008. J Natl Cancer Inst 105: 1096-1110.
10. Götze S, Wolter M, Reifenberger G, Müller O, Sievers S (2010) Frequent promoter hypermethylation of Wnt pathway inhibitor genes in malignant astrocytic gliomas. Int J Cancer 126: 2584-2593.
11. Hahn SA, Schutte M, Hoque AT, Moskaluk CA, da Costa LT, Rozenblum E, Weinstein CL, Fischer A, Yeo CJ, Hruban RH, Kern SE (1996) DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1. Science 271: 350-353.
12. Hirata H, Ueno K, Nakajima K, Tabatabai ZL, Hinoda Y, Ishii N, Dahiya R (2013) Genistein downregulates onco-miR-1260b and inhibits Wnt-signalling in renal cancer cells. Br J Cancer 108: 2070-2078.
13. Horvath LG, Henshall SM, Kench JG, Turner JJ, Golovsky D, Brenner PC, O'Neill GF, Kooner R, Stricker PD, Grygiel JJ, Sutherland RL (2004) Loss of BMP2, Smad8, and Smad4 expression in prostate cancer progression. Prostate 59: 234-242.
14. Inui M, Martello G, Piccolo S (2010) MicroRNA control of signal transduction. Nat Rev Mol Cell Biol 11: 252-263.
15. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D (2011) Global cancer statistics. CA Cancer J Clin 61: 69-90.
16. Jian L (2009) Soy, isoflavones, and prostate cancer. Mol Nutr Food Res 53: 217-226.
17. Katanoda K, Matsuda T, Matsuda A, Shibata A, Nishino Y, Fujita M, Soda M, Ioka A, Sobue T, Nishimoto H (2013) An updated report of the trends in cancer incidence and mortality in Japan. Jpn J Clin Oncol 43: 492-507.
18. Kaufman PB, Duke JA, Brielmann H, Boik J, Hoyt JE (1997) A comparative survey of leguminous plants as sources of the isoflavones, genistein and daidzein: implications for human nutrition and health. J Altern Complement Med 3: 7-12.
19. Kawano Y, Kypta R (2003) Secreted antagonists of the Wnt signalling pathway. J Cell Sci 116: 2627-2634.
20. Lambrot R, Kimmins S (2011) Histone methylation is a critical regulator of the abnormal expression of POU5F1 and RASSF1A in testis cancer cell lines. Int J Androl 34: 110-123.
21. Lazarevic B, Boezelijn G, Diep LM, Kvernrod K, Ogren O, Ramberg H, Moen A, Wessel N, Berg RE, Egge-Jacobsen W, Hammarstrom C, Svindland A, Kucuk O, Saatcioglu F, Taskèn KA, Karlsen SJ (2011) Efficacy and safety of short-term genistein intervention in patients with localized prostate cancer prior to radical prostatectomy: a randomized, placebo-controlled, double-blind Phase 2 clinical trial. Nutr Cancer 63: 889-898.
22. Li LC, Dahiya R (2002) MethPrimer: designing primers for methylation PCRs. Bioinformatics 18: 1427-1431.
23. Li M, Zhang Z, Hill DL, Chen X, Wang H, Zhang R (2005) Genistein, a dietary isoflavone, down-regulates the MDM2 oncogene at both transcriptional and posttranslational levels. Cancer Res 65: 8200-8208.
24. Li Y, Sarkar FH (2002) Inhibition of nuclear factor kappaB activation in PC3 cells by genistein is mediated via Akt signaling pathway. Clin Cancer Res 8: 2369-2377.
25. Liu L, Noone AM, Gomez SL, Scoppa S, Gibson JT, Lichtensztajn D, Fish K, Wilkens LR, Goodman MT, Morris C, Kwong S, Deapen D, Miller BA (2013) Cancer incidence trends among native Hawaiians and other Pacific islanders in the United States, 1990-2008. J Natl Cancer Inst 105: 1086-1095.
26. Lodygin D, Epanchintsev A, Menssen A, Diebold J, Hermeking H (2005) Functional epigenomics identifies genes frequently silenced in prostate cancer. Cancer Res 65: 4218-4227.
27. Mentor-Marcel R, Lamartiniere CA, Eltoum IE, Greenberg NM, Elgavish A (2001) Genistein in the diet reduces the incidence of poorly differentiated prostatic adenocarcinoma in transgenic mice (TRAMP). Cancer Res 61: 6777-6782.
28. Namiki M, Akaza H, Lee SE, Song JM, Umbas R, Zhou L, Lee BC, Cheng C, Chung MK, Fukagai T, Hinotsu S, Horie S (2010) Prostate cancer working group report. Jpn J Clin Oncol Suppl 1: i70-i75.
29. Øster B, Linnet L, Christensen LL, Thorsen K, Ongen H, Dermitzakis ET, Sandoval J, Moran S, Esteller M, Hansen TF, Lamy P, COLOFOL steering groupLaurberg S, Ørntoft TF, Andersen CL (2013) Non-CpG island promoter hypomethylation and miR-149 regulate the expression of SRPX2 in colorectal cancer. Int J Cancer 132: 2303-2315.
30. Ozten-Kandaş N, Bosland MC (2011) Chemoprevention of prostate cancer: natural compounds, antiandrogens, and antioxidants-in vivo evidence. J Carcinog 10: 27.
31. Perry AS, Liyanage H, Lawler M, Woodson K (2007) Discovery of DNA hypermethylation using a DHPLC screening strategy. Epigenetics 2: 43-49.
32. Phillip CJ, Giardina CK, Bilir B, Cutler DJ, Lai YH, Kucuk O, Moreno CS (2012) Genistein cooperates with the histone deacetylase inhibitor vorinostat to induce cell death in prostate cancer cells. BMC Cancer 12: 145.
33. Rabiau N, Trraf HK, Adjakly M, Bosviel R, Guy L, Fontana L, Bignon YJ, Bernard-Gallon DJ (2011) miRNAs differentially expressed in prostate cancer cell lines after soy treatment. In Vivo 25: 917-921.
34. Riggins GJ, Kinzler KW, Vogelstein B, Thiagalingam S (1997) Frequency of Smad gene mutations in human cancers. Cancer Res 57: 2578-2580.
35. Roemeling S, Roobol MJ, de Vries SH, Gosselaar C, van der Kwast TH, Schröder FH (2006) Prevalence, treatment modalities and prognosis of familial prostate cancer in a screened population. J Urol 175: 1332-1336.
36. Shukla S, Gupta S (2005) Dietary agents in the chemoprevention of prostate cancer. Nutr Cancer 53: 18-32.
37. Siegel R, Naishadham D, Jemal A (2012) Cancer statistics, 2012. CA Cancer J Clin 62: 10-29.
38. Suzuki H, Toyota M, Carraway H, Gabrielson E, Ohmura T, Fujikane T, Nishikawa N, Sogabe Y, Nojima M, Sonoda T, Mori M, Hirata K, Imai K, Shinomura Y, Baylin SB, Tokino T (2008) Frequent epigenetic inactivation of Wnt antagonist genes in breast cancer. Br J Cancer 98: 1147-1156.
39. Suzuki H, Watkins DN, Jair KW, Schuebel KE, Markowitz SD, Chen WD, Pretlow TP, Yang B, Akiyama Y, Van Engeland M, Toyota M, Tokino T, Hinoda Y, Imai K, Herman JG, Baylin SB (2004) Epigenetic inactivation of SFRP genes allows constitutive WNT signaling in colorectal cancer. Nat Genet 36: 417-422.
40. Swigut T, Wysocka J (2007) H3K27 demethylases, at long last. Cell 131: 29-32.
41. Vardi A, Bosviel R, Rabiau N, Adjakly M, Satih S, Dechelotte P, Boiteux JP, Fontana L, Bignon YJ, Guy L, Bernard-Gallon DJ (2010) Soy phytoestrogens modify DNA methylation of GSTP1, RASSF1A, EPH2 and BRCA1 promoter in prostate cancer cells. In Vivo 24: 393-400.
42. Wang J, Eltoum IE, Lamartiniere CA (2004) Genistein alters growth factor signaling in transgenic prostate model (TRAMP). Mol Cell Endocrinol 219: 171-180.
43. Wang Z, Zang C, Rosenfeld JA, Schones DE, Barski A, Cuddapah S, Cui K, Roh TY, Peng W, Zhang MQ, Zhao K (2008) Combinatorial patterns of histone acetylations and methylations in the human genome. Nat Genet 40: 897-903.
44. Xu L, Ding Y, Catalona WJ, Yang XJ, Anderson WF, Jovanovic B, Wellman K, Killmer J, Huang X, Scheidt KA, Montgomery RB, Bergan RC (2009) MEK4 function, genistein treatment, and invasion of human prostate cancer cells. J Natl Cancer Inst 101: 1141-1155.
45. Yang G, Yang X (2010) Smad4-mediated TGF-beta signaling in tumorigenesis. Int J Biol Sci 6: 1-8.
46. Yin Z, Babaian RJ, Troncoso P, Strom SS, Spitz MR, Caudell JJ, Stein JD, Kagan J (2001) Limiting the location of putative human prostate cancer tumor suppressor genes on chromosome 18q. Oncogene 20: 2273-2280.